{"related:VJaxlcLSG98J:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5":[{"title":"The new pharmaceutical policy in Italy","url":"https://www.sciencedirect.com/science/article/pii/S0168851098000475","authors":["G Fattore","G Fattore C Jommi"],"year":1998,"numCitations":72,"citationUrl":"http://scholar.google.com/scholar?cites=16076675028006049364&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:VJaxlcLSG98J:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16076675028006049364&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Elsevier","p":1,"exp":1596876810173},{"title":"The management of the cost and utilisation of pharmaceuticals in the United Kingdom","url":"https://www.sciencedirect.com/science/article/pii/S0168851097000511","authors":["ML Burstall"],"year":1997,"numCitations":46,"citationUrl":"http://scholar.google.com/scholar?cites=14032647515530436370&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:Ep91NZH6vcIJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14032647515530436370&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Elsevier"},{"title":"Cost and utilisation of pharmaceuticals in Sweden","url":"https://www.sciencedirect.com/science/article/pii/S0168851097000535","authors":["MO Ljungkvist","MO Ljungkvist D Andersson","MO Ljungkvist D Andersson B Gunnarsson"],"year":1997,"numCitations":31,"citationUrl":"http://scholar.google.com/scholar?cites=13110491095735515344&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:0Lg8cDDS8bUJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13110491095735515344&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Elsevier"},{"title":"What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?","url":"https://www.sciencedirect.com/science/article/pii/S0168851098000232","authors":["S Schneeweiss","S Schneeweiss O Schöffski","S Schneeweiss O Schöffski GW Selke"],"year":1998,"numCitations":62,"pdf":"https://www.researchgate.net/profile/Sebastian_Schneeweiss/publication/13116416_What_is_Germany's_experience_on_reference_based_drug_pricing_and_the_etiology_of_adverse_health_outcomes_or_substitution/links/5d5cbc61458515210254dbe4/What-is-Germanys-experience-on-reference-based-drug-pricing-and-the-etiology-of-adverse-health-outcomes-or-substitution.pdf","citationUrl":"http://scholar.google.com/scholar?cites=11561255053678108617&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:yV8smDfUcaAJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11561255053678108617&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Elsevier"},{"title":"The German experience in reference pricing","url":"https://www.sciencedirect.com/science/article/pii/S0168851098000128","authors":["G Giuliani","G Giuliani G Selke","G Giuliani G Selke L Garattini"],"year":1998,"numCitations":155,"citationUrl":"http://scholar.google.com/scholar?cites=10318633683380081773&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:bRRAIaomM48J:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10318633683380081773&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Elsevier"},{"title":"Cost-containment measures in the Italian healthcare system","url":"https://link.springer.com/article/10.2165/00019053-199508020-00001","authors":["V Mapelli"],"year":1995,"numCitations":20,"citationUrl":"http://scholar.google.com/scholar?cites=4068835391412677768&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:iKywGjtodzgJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4068835391412677768&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Springer"},{"title":"Drug cost containment policies in Italy: are they really effective in the long-run?: The case of minimum reference price","url":"https://www.sciencedirect.com/science/article/pii/S0168851099000706","authors":["V Atella"],"year":2000,"numCitations":62,"pdf":"http://www.academia.edu/download/49622376/health_20policy_202000_20atella.pdf","citationUrl":"http://scholar.google.com/scholar?cites=8414699701000112888&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:-IqyicsEx3QJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8414699701000112888&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Elsevier"},{"title":"Management of cost and utilization of pharmaceuticals in Germany","url":"https://www.sciencedirect.com/science/article/pii/S0168851097000523","authors":["JMG von der Schulenburg"],"year":1997,"numCitations":22,"citationUrl":"http://scholar.google.com/scholar?cites=16770054786258315444&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:tCjE_vkzu-gJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16770054786258315444&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Elsevier"},{"title":"Pharmaceutical reference prices","url":"https://link.springer.com/article/10.2165/00019053-199814050-00002","authors":["M Dickson","M Dickson H Redwood"],"year":1998,"numCitations":98,"citationUrl":"http://scholar.google.com/scholar?cites=15745196105678669012&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:1ETXvW8sgtoJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15745196105678669012&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Springer"},{"title":"Spending on pharmaceuticals in Italy: macro constraints with local autonomy","url":"https://onlinelibrary.wiley.com/doi/abs/10.1046/j.1524-4733.6.s1.4.x","authors":["V Mapelli","V Mapelli C Lucioni"],"year":2003,"numCitations":33,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1524-4733.6.s1.4.x","citationUrl":"http://scholar.google.com/scholar?cites=15103987803730438050&as_sdt=2005&sciodt=0,5&hl=en&scioq=pharmaceutical+policy","relatedUrl":"http://scholar.google.com/scholar?q=related:omcvFeIknNEJ:scholar.google.com/&scioq=pharmaceutical+policy&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15103987803730438050&hl=en&as_sdt=0,5&scioq=pharmaceutical+policy","publication":"Wiley Online Library"}]}